43 Evaluation and Treatment for ADHD :: University Health Service

University of Rochester

Please send questions about the technical structure/operation to the UHS Web Master

Last modified: Friday, 11-Aug-2017 08:25:48 EDT

University Health Service (UHS)

Evaluation and Treatment for ADHD
(Attention Deficit Hyperactivity Disorder)

Attention Deficit Hyperactivity Disorder (ADHD) is a developmental disorder that commonly presents initially during childhood and is characterized by developmentally atypical levels of inattention and/or hyperactive-impulsive behavior. For a person to be diagnosed with ADHD, symptoms of inattention and/or hyperactive-impulsive behavior must cause significant impairment in two or more major life activities, including interpersonal relations, educational or occupational goals, and/or cognitive or adaptive functioning.

There is no simple definitive test for the disorder, and there is significant geographic variation in the diagnosis. Treatment always includes behavioral strategies to improve functioning. In addition, medications may sometimes be helpful. Educational institutions may make accommodations for learning and testing.

Guidelines for Evaluation and Treatment for ADHD

The University Health Service (UHS) has adopted the following guidelines for students who request prescription medications for ADHD. Please consider the following options to determine the appropriate course of action:

If you are not requesting medications for ADHD through UHS:

If you are requesting medications through UHS and have been:

Documentation Requirements:

Documentation must be in the form of an evaluation/treatment summary, and/or (neuro) psychological assessment supporting the diagnosis. Progress notes alone are not sufficient. The diagnostic report should, where appropriate, include:

Submitting Documentation: Documentation should be sent to the University Health Service by one of the following ways:

Medication Treatment

In part due to the complexity of appropriately determining whether the presentation and history warrant an ADHD diagnosis and consideration of treatment with a controlled substance, UHS providers do not currently provide ADHD-targeted controlled-substance stimulants at initial visits; it is important for students who chronically take prescribed controlled-substance stimulants to work with their current non-UHS providers to facilitate appropriate access to medication while student is exploring the possibility of UHS-prescribed controlled-substance stimulants.

If a controlled substance is going to be prescribed by a UHS health care provider, you will be asked to sign the "UHS Controlled Medication Agreement."

This agreement will be reviewed and signed by your primary care provider or psychiatrist when you receive your first prescription for ADHD medications. The purpose of this agreement is to assure compliance with all applicable state and federal laws regarding controlled medications and to prevent misunderstandings about the proper use of these medications. Lost or stolen medications will not be replaced. Periodic urine drug screening may occur. Medications for ADHD are potentially lethal, as well as having been associated with substance use disorder. Giving or selling medications to others is against the law and a violation of University policy.

Requesting Classroom Accommodations

Students seeking academic accommodations should contact the Office of Disability Resources, meet with an access coordinator and submit supporting documentation in accordance with the University of Rochester Equal Opportunity Policy. Students with ADHD often find Study Skills Counseling beneficial. Study skills consultants at the Center for Excellence in Teaching and Learning (CETL) can provide assistance related to time management, test-taking strategies, and motivation. Additionally, CETL offers a 1-credit study skills course, Methods of Inquiry. UHS may require you to have an initial consultation with CETL as a condition of prescribing a controlled substance for ADHD.

Additional Information